Stiripentol add‐on therapy for drug‐resistant focal epilepsy

This updated review (1 study; nothing new) finds that no conclusions can be drawn to support the use of stiripentol as add-on treatment for drug-resistant focal epilepsy. Additional large, randomised, well-conducted trials are needed.

Cochrane Database of Systematic Reviews